The pharma e-commerce market in Europe is projected to expand by USD 38.7 billion at a CAGR of 16.27% from 2023 to 2028. The rising adoption of e-pharmacies, driven by convenience, competitive pricing, and accessibility, is fueling growth, especially in newly regulated European states. However, illegal and counterfeit drug trading poses a significant challenge, prompting regulatory interventions. The increasing availability of medications and digital healthcare advancements is reshaping the market landscape.
For more details about the industry, get the PDF sample report for free
Pharma e-commerce involves the online sale of medications, medical supplies, and healthcare products. The market is expanding due to factors such as the aging population, chronic diseases, and demand for convenient healthcare solutions. Online and mail-order pharmacies are gaining popularity, along with telemedicine and e-prescriptions. However, concerns regarding illegal online pharmacies, counterfeit drugs, and data security persist.
Key trends include:
Omnichannel retailing by pharmacy chains is a primary growth driver. Retail pharmacy chains in Europe are integrating online services and mobile applications with physical stores, offering real-time inventory data, logistics, and stock availability updates.
With the widespread use of smartphones and tablets, omnichannel retailing has gained momentum, allowing seamless online and offline interactions. Pharmacies are investing in website upgrades and infrastructure development to enhance product inventory management, despite the capital-intensive nature of these expansions.
The rising elderly population and chronic diseases are influencing market growth. The European Union (EU) has a higher life expectancy, leading to increased cases of diabetes, arthritis, cancer, heart disease, asthma, and COPD. These conditions drive demand for online medicine purchases, reducing the need for physical pharmacy visits and ensuring timely delivery of medications.
The growing geriatric population requires regular medication for chronic conditions, further boosting e-pharmacy adoption.
The difficulty in retaining online customer loyalty is a significant challenge. Unlike physical stores, where staff can guide consumers, online buyers must independently navigate product selections. This lack of assistance can lead to hesitation in purchasing medicines.
Moreover, unintuitive web pages can drive consumers to competitors. To counteract this, companies are employing SEO techniques and consumer data analytics to personalize offerings and improve engagement.
The medications segment holds a significant market share, driven by rising demand due to aging populations and chronic diseases. Online and mail-order pharmacies provide convenience, while telemedicine and digital prescriptions streamline healthcare services.
Despite concerns about illegal and unregulated pharmacies, market players are leveraging AI, digital healthcare, and mobile applications to enhance consumer confidence. Trends such as biometric identification, two-factor authentication, and manufacturer-owned marketplaces are shaping the future of the sector.
The market is expanding across key European countries.
Get more details by ordering the complete report
The competitive landscape features companies implementing strategies such as alliances, mergers, acquisitions, and geographical expansion.
Key players include:
The European pharma e-commerce market is poised for sustained growth, driven by digital healthcare advancements, an aging population, and chronic disease prevalence. The integration of AI, data analytics, and telemedicine will play a crucial role in shaping the industry's future.
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
